REQUEST A DEMO
Total
USD $0.00
Search more companies

Subira Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Subira Pharmaceuticals Private Limited Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Subira Pharmaceuticals Private Limited is an unlisted company, incorporated on 08/10/2013. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U24233MH2013PTC328984 and registration number is 328984. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
A-408, Fairlink Centre Chs Ltd. Off. Link Road, Andheri West
Mumbai; Maharashtra; Postal Code: 400053

Contact Details: Purchase the Subira Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Subira Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Subira Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
October 08, 2013
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Subira Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
32.2%
Total operating revenue
31.92%
Operating profit (EBIT)
91.16%
EBITDA
84.81%
Net Profit (Loss) for the Period
92.2%
Total assets
30.59%
Total equity
33.51%
Operating Profit Margin (ROS)
4.45%
Net Profit Margin
3.35%
Return on Equity (ROE)
7.66%
Debt to Equity Ratio
-0.66%
Quick Ratio
0.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?